Russia to sell 100 million doses of COVID-19 vaccine to India
FILE PHOTO: A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File PhotoRussia’s sovereign wealth fund said on Wednesday it will supply India’s Dr. Reddy’s Laboratories with 100 million doses of the Sputnik-V vaccine against COVID-19 once it receives regulatory approval in India.
The deal comes after the Russian Direct Investment Fund (RDIF) reached agreements with Indian manufacturers to produce 300 million doses of the vaccine in India, which is a major consumer of Russian oil and arms.
Dr Reddy’s, one of India’s top pharmaceutical companies, will carry out Phase III clinical trials of the vaccine in the country, pending regulatory approval, RDIF said in a statement.
However, the deliveries to India, where coronavirus cases have surged past five million, could begin before the end of this year.
SOURCE: AGENCEY
PHOTO: A woman holds a small bottle labeled with a “Vaccine COVID-19” sticker and a medical syringe in this illustration. REUTERS
The Times of Earth ( TOE) founded in 1999, is a multilingual newspaper that is printed and circulated in many countries including some parts of the United States and Canada. It is considered as the largest trusted & respected international multimedia news/financial information source of the world.